A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Union of Health Insurance companies, against the decision of the State Institute for Drug Control from 21. 8. 2020,
under the no. SUKLS62604/2020:
the decision under
appeal is reversed and the issue is referred back to the State Institute for
Drug Control for reappraisal.
A decision of the Ministry of Health regarding the appeal of the appelant Union of Health Insurance companies - part of the decision is reversed and the issue is referred back for reappraisal.
A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Union of Health Insurance companies, against the decision of the State Institute for Drug Control from 9. 10. 2020,
under the no. SUKLS104884/2020:
the decision under
appeal is reversed and the issue is referred back to the State Institute for
Drug Control for reappraisal.
A decision of the Ministry of Health regarding the appeal of the appelant Union of Health Insurance companies - part of the decision is reversed and the issue is referred back for reappraisal.
A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Union of Health Insurance companies, against the decision of the State Institute for Drug Control from 10. 9. 2021,
under the no. SUKLS231399/2021:
the decision under
appeal is reversed and the issue is referred back to the State Institute for
Drug Control for reappraisal.
A decision of the Ministry of Health regarding the appeal of the appelant Union of Health Insurance companies - part of the decision is reversed and the issue is referred back for reappraisal.
A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Egis Pharmaceuticals PLC, against the decision of the State Institute for Drug Control from 15. 11. 2019, under the no.: SUKLS242039/2019:
the remainder of the appeal is dismissed and the decision under appeal is upheld.
A decision of the Ministry of Health regarding the appeal of the appelant Health Insurance Companies - the appeal is dismissed and the decision under appeal is upheld.
A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelants AstraZeneca AB and Union of Health Insurance companies, against the decision of the State Institute for Drug Control from 4. 10. 2019,
under the no.SUKLS55717/2016:
the decision under
appeal is reversed and the issue is referred back to the State Institute for
Drug Control for reappraisal.
A decision of the Ministry of Health regarding the appeal of the appelants AstraZeneca AB and Union of Health Insurance companies - part of the decision is reversed and the issue is referred back...
A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Health Insurance Companies, against the decision of the State Institute for Drug Control from 31. 10. 2019, under the no.: SUKLS192185/2019:
the remainder of the appeal is dismissed and the decision under appeal is upheld.
A decision of the Ministry of Health regarding the appeal of the appelant Health Insurance Companies - the appeal is dismissed and the decision under appeal is upheld.
A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Union of Health Insurance companies, against the decision of the State Institute for Drug Control from 27. 6. 2019,
under the no.SUKLS96435/2017:
the decision under
appeal is reversed and the issue is referred back to the State Institute for
Drug Control for reappraisal.
A decision of the Ministry of Health regarding the appeal of the appelant Union of Health Insurance companies - part of the decision is reversed and the issue is referred back for reappraisal.
A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant General Health Insurance Company against the decision of the State Institute for Drug Control from 27. 9. 2019, under the no.: SUKLS339889/2018:
part 2 of the decision is dismissed and the rest of
the decision is referred back for reappraisal
part 1 of the decision is dismissed and the rest of
the decision is upheld
A decision of the Ministry of Health regarding the appeal of the appelant General Health Insurance Company - part of the decision is dismissed and the rest of the decision is referred back for...
A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Takeda France SAS, against the decision of the State Institute for Drug Control from 12. 11. 2019,
under the no. SUKLS214103/2014:
the decision under
appeal is reversed and the issue is referred back to the State Institute for
Drug Control for reappraisal.
A decision of the Ministry of Health regarding the appeal of the appelant Takeda France SAS - part of the decision is reversed and the issue is referred back for reappraisal.
A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Nutricia a.s, against the decision of the State Institute for Drug Control from 29. 3. 2019,
under the no. SUKLS206741/2016:
the decision under
appeal is reversed and the issue is referred back to the State Institute for
Drug Control for reappraisal.
A decision of the Ministry of Health regarding the appeal of the appelant Nutricia a.s - part of the decision is reversed and the issue is referred back for reappraisal.
A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Nutricia a.s, against the decision of the State Institute for Drug Control from 29. 3. 2019,
under the no. SUKLS206739/2016:
the decision under
appeal is reversed and the issue is referred back to the State Institute for
Drug Control for reappraisal.
A decision of the Ministry of Health regarding the appeal of the appelant Nutricia a.s - part of the decision is reversed and the issue is referred back for reappraisal.
A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Nutricia a.s, against the decision of the State Institute for Drug Control from 29. 3. 2019,
under the no. SUKLS206734/2016:
the decision under
appeal is reversed and the issue is referred back to the State Institute for
Drug Control for reappraisal.
A decision of the Ministry of Health regarding the appeal of the appelant Nutricia a.s - part of the decision is reversed and the issue is referred back for reappraisal.
A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Nutricia a.s, against the decision of the State Institute for Drug Control from 29. 3. 2019,
under the no. SUKLS206734/2016:
the decision under
appeal is reversed and the issue is referred back to the State Institute for
Drug Control for reappraisal.
A decision of the Ministry of Health regarding the appeal of the appelant Nutricia a.s - part of the decision is reversed and the issue is referred back for reappraisal.
A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Nutricia a.s, against the decision of the State Institute for Drug Control from 29. 3. 2019,
under the no. SUKLS206730/2016:
the decision under
appeal is reversed and the issue is referred back to the State Institute for
Drug Control for reappraisal.
A decision of the Ministry of Health regarding the appeal of the appelant Nutricia a.s - part of the decision is reversed and the issue is referred back for reappraisal.
A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Nutricia a.s, against the decision of the State Institute for Drug Control from 29. 3. 2019,
under the no. SUKLS206732/2016:
the decision under
appeal is reversed and the issue is referred back to the State Institute for
Drug Control for reappraisal.
A decision of the Ministry of Health regarding the appeal of the appelant Nutricia a.s - part of the decision is reversed and the issue is referred back for reappraisal.
A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant AbbVie Deutschland GmbH & Co.KG., against the decision of the State Institute for Drug Control from 26. 8. 2021, under the no.: SUKLS240282/2021:
the remainder of the appeal is dismissed and the decision under appeal is upheld.
A decision of the Ministry of Health regarding the appeal of the appelant AbbVie Deutschland GmbH & Co.KG. - the appeal is dismissed and the decision under appeal is upheld.
